Drug-Coated Balloons: Current Outcomes and Future Directions

Ananya Kondapalli, Barbara A. Danek, Houman Khalili, Haekyung Jeon-Slaughter, Subhash Banerjee

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

Original languageEnglish (US)
Pages (from-to)217-225
Number of pages9
JournalInterventional Cardiology Clinics
Volume6
Issue number2
DOIs
StatePublished - Apr 1 2017

Keywords

  • Drug-coated balloons
  • Endovascular intervention
  • Femoropopliteal peripheral artery
  • Infrapopliteal peripheral artery
  • Paclitaxel

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Drug-Coated Balloons: Current Outcomes and Future Directions'. Together they form a unique fingerprint.

  • Cite this